Healthcare stocks drop after Obamacare ruling

Amy Baxter | | Health Exec | Policy & Regulations
Stocks

Healthcare stocks were jolted after news of a Texas judge’s ruling that the Affordable Care Act was unconstitutional, with hospital and insurance stocks among the worst performers of a selloff on Dec. 17, Bloomberg reported.

The ruling, which was handed down on Dec. 14, overturns the ACA. It has thrown the future of the healthcare system into flux, though the healthcare law will remain in place while the case faces an appeals process.

U.S. hospitals fell 4.4 percent on Monday, the lowest level since March 1, according to Bloomberg. Elsewhere, the S&P 500 Managed Care Index dropped 2.3 percent, while Molina dipped as much as 13.5 percent. Molina and Centene are currently facing the biggest losses on the market due to their high exposures to Medicaid and Obamacare markets.

See the full story below:

Hospitals, Insurers Sink as Obamacare Ruling Jolts Investors

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

More than 1,000 hospitals earn $700M opioid crisis judgment
VA planning 83,000 layoffs as part of restructuring
HIMSS survey report: Beware insider threats to cybersecurity involving AI
HHS spokesperson abruptly resigns, reportedly after clash with RFK
Hospital faces $3.5M settlement after sharing patient data with Facebook
Philips pulls endovascular devices from market after safety issues prompt Class I recall

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.